- Researchers have found that a novel drug molecule may fight the development of early-onset Parkinson’s disease in younger people.
- The new compound, BIO-2007817, is from the family of tetrahydropyrazolo-pyrazine (THPP) compounds.
- It offered promising results in activating parkin, a key protein in the brain responsible for tagging damaged proteins in mitochondria.
- Experts say the molecule’s ability to assist patients with early-onset Parkinson’s is promising, but more research is needed to…
Read the full article here